MGIM
TPTX

M&G Investment Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

M&G Investment Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,149
Closed -$274 – 789
2021
Q3 		$274 Sell
4,149
-2,882
-41% -$205K ﹤0.01% 704
2021
Q2 		$548 Buy
+7,031
New +$520K ﹤0.01% 671

Other funds holding TPTX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

M&G Investment Management's TPTX Position: Q4 2021 in Review

M&G Investment Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q4 2021, closing a stake of 4,149 shares — an estimated $274 sold.

M&G Investment Management first reported a position in TPTX in Q2 2021 and held it in 2 quarters. The position peaked at $548 in Q2 2021. 172 funds tracked by Wall St. Rank hold TPTX as of Q4 2021.

  • M&G Investment Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 4,149 Turning Point Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $274.
  • M&G Investment Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $548 in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.